Sahlgrenska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

2019

  1. Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

    Alzheimer's Research and Therapy, Vol. 11, Núm. 1